Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kinetics of B Cell Response to Menjugate in Infants
NCT00310700Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2005
- Primary completion
- Nov 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal group c conjugate vaccine in Meningococcal group C infection, sponsored by Novartis. Started May 2005; status: completed.
02
Drugs
meningococcal group c conjugate vaccine
03
Conditions
Meningococcal group C infection
Beyond the preview
Go deeper on NCT00310700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310700.